Related Experiment Videos
Memory after treatment for acute lymphoblastic leukaemia
J Rodgers1, P G Britton, R G Morris
1Psychiatry Research Unit, Royal Victoria Infirmary, Newcastle upon Tyne.
Archives of Disease in Childhood
|March 1, 1992
Summary
Long term survivors of acute lymphoblastic leukaemia (ALL) experience memory deficits, particularly in strategic planning tasks. These cognitive challenges in childhood cancer survivors may be improved with targeted educational interventions.
Area of Science:
- Neuroscience
- Pediatric Oncology
- Cognitive Psychology
Background:
- Long-term survivors of acute lymphoblastic leukaemia (ALL) frequently report cognitive impairments.
- Memory function is a key area of concern, potentially impacting quality of life.
- Previous research indicates a need for better understanding of these specific deficits.
Purpose of the Study:
- To investigate memory function in acute lymphoblastic leukaemia (ALL) survivors.
- To compare memory abilities between ALL survivors, sibling controls, and other cancer patient groups.
- To identify specific cognitive deficits in ALL survivors and explore potential remediation strategies.
Main Methods:
- A cohort of ALL survivors was assessed for memory abilities.
- Sibling controls and children treated for other cancers served as comparison groups.
- Memory tasks specifically targeting strategic planning behaviour were administered.
Main Results:
- Children treated for acute lymphoblastic leukaemia (ALL) demonstrated significant deficits in memory function.
- These deficits were most pronounced in tasks requiring strategic planning.
- No significant differences were noted between ALL survivors and other cancer groups in these specific tasks, suggesting a unique impact of ALL treatment.
Conclusions:
- Acute lymphoblastic leukaemia (ALL) survivors exhibit specific memory impairments related to strategic planning.
- These cognitive deficits are potentially amenable to intervention.
- Educational strategies may offer a viable approach to remediate memory function in childhood cancer survivors.